Universität Wien

270047 VO From Synthesis to the Science and Strategy of Medicinal Chemistry (2023W)

4.00 ECTS (2.00 SWS), SPL 27 - Chemie

An/Abmeldung

Hinweis: Ihr Anmeldezeitpunkt innerhalb der Frist hat keine Auswirkungen auf die Platzvergabe (kein "first come, first served").

Details

Sprache: Englisch

Prüfungstermine

Lehrende

Termine (iCal) - nächster Termin ist mit N markiert

Dienstag 24.10. 14:00 - 16:00 Seminarraum 3 Organische Chemie 1OG Boltzmanngasse 1
Mittwoch 25.10. 14:00 - 16:00 Carl Auer v. Welsbach-Hörsaal Chemie Boltzmanngasse 1 HP
Mittwoch 22.11. 14:00 - 16:00 Carl Auer v. Welsbach-Hörsaal Chemie Boltzmanngasse 1 HP
Donnerstag 23.11. 14:00 - 16:00 Carl Auer v. Welsbach-Hörsaal Chemie Boltzmanngasse 1 HP
Mittwoch 29.11. 14:00 - 16:00 Carl Auer v. Welsbach-Hörsaal Chemie Boltzmanngasse 1 HP
Donnerstag 30.11. 14:00 - 16:00 Carl Auer v. Welsbach-Hörsaal Chemie Boltzmanngasse 1 HP
Montag 22.01. 14:00 - 16:00 Hörsaal 4 Chemie HP Währinger Straße 42

Information

Ziele, Inhalte und Methode der Lehrveranstaltung

The course aims to provide students with theoretical and practical medicinal chemistry background on the initial phase of small molecule drug discovery. At the completion of the course students will be able to critically analyze drug-target binding and design their own small molecule drug candidates. The course will cover the following topics:
1. Classes of small molecule drugs an introduction
2. Classes of drug targets an introduction
3. The thermodynamics of drug-target binding
4. The importance of water
5. Molecular interactions – up close & personal
6. Drug design strategies & medicinal chemistry rules of thumb
7. An introduction to finding hits in the vastness of chemical space
Further topics in medicinal chemistry that will not be covered in the course are (1) optimization of cellular and in vivo efficacy, (2) selectivity and toxicity, (3) drug distribution, metabolism and pharmacokinetics

Art der Leistungskontrolle und erlaubte Hilfsmittel

Working in small teams, students will be asked to critique a medicinal chemistry example from the literature and proposed improved molecules. The critique and design proposals will be commicated in the form of a short team presentation followed by discussion.

Mindestanforderungen und Beurteilungsmaßstab

Scale 1-5; participation in the final team presentation/exam is mandatory

Prüfungsstoff

1. The thermodynamics of drug-target binding
2. The importance of water
3. Molecular interactions
4. Drug design strategies & medicinal chemistry rules of thumb

Literatur

Hunter, Christopher A. "Quantifying intermolecular interactions: guidelines for the molecular recognition toolbox." Angewandte Chemie International Edition 43.40 (2004): 5310-5324.
Bissantz, Caterina, Bernd Kuhn, and Martin Stahl. "A medicinal chemist’s guide to molecular interactions." Journal of medicinal chemistry 53.14 (2010): 5061-5084
McConnell, Darryl B. "Biotin’s lessons in drug design." Journal of Medicinal Chemistry 64.22 (2021): 16319-16327.

Zuordnung im Vorlesungsverzeichnis

CH-SYN-02

Letzte Änderung: Mo 11.03.2024 11:08